- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The fluorescence imaging technology company has agreed to sell to Stryker for $11.75 per share.
The medical device maker will pay $701 million for NOVADAQ.
Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.